OMEPRAZOLE PHARMACEUTICAL PREPARATION Russian patent published in 2003 - IPC

Abstract RU 2207121 C2

FIELD: medicine, pharmacology, pharmacy. SUBSTANCE: invention relates to pharmaceutical preparation of omeprazole. Pharmaceutical preparation covered by enterosoluble envelope as an active component comprises compound taken among group consisting of omeprazole, omeprazole alkaline salt, (-)- enantiomer omeprazole and (-)-enantiomer omeprazole alkaline salt. This preparation comprises core comprising an active component and, possibly, alkaline reagent being an active component is in the mixture with pharmaceutically acceptable excipient, as such, binding agent and separating layer and enterosoluble enveloper layer are applied on indicated core material. For preparing pharmaceutical preparations hydroxypropylmethylcellulose with the definite cloud point is used. Except for, invention describes methods for preparing and usage of the claimed preparations in medicine. Invention provides preparing preparation useful for oral administration of omeprazole. EFFECT: improved preparing methods, valuable medicinal and pharmaceutical properties of preparation. 13 cl, 1 tbl, 3 dwg

Similar patents RU2207121C2

Title Year Author Number
PHARMACEUTICAL MEDICINAL FORMS FOR ORAL INTAKE CONTAINING INHIBITOR OF PROTON PUMP AND AGENT FOR NONSTEROID ANTI-INFLAMMATORY THERAPY 1996
  • Ehlen Depjui
  • Per Jokhan Lundberg
RU2158138C2
METHOD OF PREPARING PHARMACEUTICAL MEDICINAL FORM, METHOD OF INHIBITION OF ACID SECRETION IN STOMACH OF MAMMALS AND HUMANS 1996
  • Lundberg Per Jokhan
  • Levgren Kurt
RU2170090C2
MEDICINAL PREPARATION FOR ORAL ADMINISTRATION CONTAINING OMEPRAZOLE MAGNESIUM SALT 1995
  • Bengtsson Siv Inga
  • Levgren Kurt Ingmar
RU2173995C2
PHARMACEUTICAL COMPOSITION WITH ENTEROSOLUBLE COATING, METHOD OF ITS PREPARING, METHOD OF TREATMENT OF PATIENTS 1994
  • Inga Siv Vengtsson
  • Kurt Ingmar Levgren
RU2138254C1
PHARMACEUTICAL COMPOSITION, METHOD OF PREPARATION THEREOF, AND TREATMENT METHOD 1993
  • Arne Torsten Ehk
  • Sven Ehrik Shestrand
RU2143899C1
TABLETTED MULTICOMPONENT MEDICINAL FORM, METHOD OF PREPARATION THEREOF, PACKAGE, AND METHOD FOR INHIBITING GASTRIC ACID SECRETION AND/OR TREATING GASTROINTESTINAL INFLAMMATORY DISEASES 1995
  • Pontus Jokhi Arvid Bergstrand
  • Kurt Ingmar Levgren
RU2160094C2
TABLETTED MULTIUNIT MEDICINAL FORM, METHOD OF ITS PREPARING, METHOD OF INHIBITION OF GASTRIC ACID SECRETION OR TREATMENT OF MAMMALS AND HUMANS WITH GASTROENTERIC DISEASES 1995
  • Pontus Jokhn Arvid Bergstrand
  • Kurt Ingmar Levgren
RU2166935C2
REGIME OF ADMINISTRATION OF INHIBITORS OF [H,K]-ATPASE 1997
  • Sederberg Krister
  • Sehchs Dzhordzh
RU2203662C2
OPTICALLY PURE Na, Mg, Li, K OR Ca SALTS OF (-)-5-METHOXY-2-[[(4- -METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL]SULFINYL]-1H-BENZ-IMIDAZOLE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON SAID AND INTERMEDIATE COMPOUND 1994
  • Per Lennart Lindberg
  • Sverker Von Unge
RU2137766C1
OMEPRAZOLE MAGNESIUM SALT, METHOD OF ITS PREPARING, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT 1994
  • Lars Oke Kel'Strem
  • Monika Annelie Njugren
RU2139868C1

RU 2 207 121 C2

Authors

Ehrikson Magnus

Jusefsson Lars

Dates

2003-06-27Published

1998-05-18Filed